Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP276466.RAZh3-Ss7vQ231GuQxrgprXN4Njv7Tf2_te7SaAfPrdE4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP276466.RAZh3-Ss7vQ231GuQxrgprXN4Njv7Tf2_te7SaAfPrdE4130_assertion type Assertion NP276466.RAZh3-Ss7vQ231GuQxrgprXN4Njv7Tf2_te7SaAfPrdE4130_head.
- NP276466.RAZh3-Ss7vQ231GuQxrgprXN4Njv7Tf2_te7SaAfPrdE4130_assertion description "[In dysplasia and cancer, significantly more epithelial cells expressed IL6 and p-STAT3 compared with controls (strong positive IL6: 72.7% and 0% respectively; p-STAT3: 54.5% and 11.1%, respectively; both p<0.05), whereas the proportion of SOCS3-positive cells in this progression reduced (LGD 33.3%; HGD 14.3%; UC-CRC 9.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276466.RAZh3-Ss7vQ231GuQxrgprXN4Njv7Tf2_te7SaAfPrdE4130_provenance.
- NP276466.RAZh3-Ss7vQ231GuQxrgprXN4Njv7Tf2_te7SaAfPrdE4130_assertion evidence source_evidence_literature NP276466.RAZh3-Ss7vQ231GuQxrgprXN4Njv7Tf2_te7SaAfPrdE4130_provenance.
- NP276466.RAZh3-Ss7vQ231GuQxrgprXN4Njv7Tf2_te7SaAfPrdE4130_assertion SIO_000772 19926618 NP276466.RAZh3-Ss7vQ231GuQxrgprXN4Njv7Tf2_te7SaAfPrdE4130_provenance.
- NP276466.RAZh3-Ss7vQ231GuQxrgprXN4Njv7Tf2_te7SaAfPrdE4130_assertion wasDerivedFrom befree-20140225 NP276466.RAZh3-Ss7vQ231GuQxrgprXN4Njv7Tf2_te7SaAfPrdE4130_provenance.
- NP276466.RAZh3-Ss7vQ231GuQxrgprXN4Njv7Tf2_te7SaAfPrdE4130_assertion wasGeneratedBy ECO_0000203 NP276466.RAZh3-Ss7vQ231GuQxrgprXN4Njv7Tf2_te7SaAfPrdE4130_provenance.